Mitsubishi Tanabe Pharma Corporation tries to get approval for commercializing oral formulation of edaravone
For amyotrophic lateral sclerosis, Mitsubishi Tanabe Pharma Corporation (MTPC) is awaiting permission to produce and commercialise MT-1186. It is an
Read more